Name |
Cabazitaxel
|
Supplier |
Biorbyt
|
Catalog |
orb153606
|
Prices |
$323.00, $417.00, $417.00, $553.00, $655.00, $1,046.00, $1,624.00
|
Sizes |
5 mg, 10 mg, 25 mg, 50 mg, 100 mg, 200 mg, 500 mg
|
Cas Number |
[183133-96-2]
|
Pubchem |
9854073
|
Chemical Name |
(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4-(Acetyloxy)-15-{[(2R,3S)-3-{[(tert-butoxy)carbonyl]amino}-2-hydroxy-3-phenylpropanoyl]oxy}-1-hydroxy-9,12-dimethoxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-ene-2-ylbenzoate
|
Formula |
C45H57NO14
|
Molecular Weight |
835.93 g/mol
|
Purity |
>99% pure
|
Description |
Cabazitaxel, also named XRP-6258, is a second-generation semi-synthetic derivative of paclitaxel, a natural taxoid 10-deacetylbaccatin III inhibitor with potential antineoplastic activity. In a variety of docetaxel-refractory antitumor activity was shown in cabazitaxel in vitro and in vivo model.
|
Supplier Page |
Shop
|